A Simple High Performance Liquid Chromatography Procedure for the Determination of N1-Methylnicotinamide in Urine

Abstract

A simple high performance liquid chromatography procedure for the determination of N¹-methylnicotinamide in urine samples is described. The procedure eliminates the need for extraction or ion exchange clean-up of urine samples prior to their analysis. Human and rat urine samples can be analyzed for N¹-methylnicotinamide directly following a simple pH adjustment. The metabolite was separated and quantitated on a 5μ Ultrasphere ODS (C18) reverse-phase column. The mobile phase contained 10 mM K₂HPO₄ and 10 mM sodium 1-octanesulfonate in 8% acetonitrile at pH 7.0. The system has been used to conduct over 1000 determinations during a period of three months without reduction in performance or efficiency.     

Ion-Selective Electrode Determination of Sodium and Potassium in Blood and Urine

Abstract

The Beckman Electrolyte 2 Analyzer (E2A) has been studied for its response to sodium and potassium content in various laboratory prepared pH-adjusted mixtures of metal chlorides in the absence and presence of albumin and α-, β-and γ -globulins. These mixtures also included MITS, a Mock Ionic Test Serm, containing sodium chloride (15OmM), potassium chloride (4mM), calcium chloride (1mM) and magnesium chloride (1mM). Results for sodium and potassium are often low for these non-clinical standards.

Responses have also been studied for patient blood serum and urine samples. Some comparisons have been made with data obtained by flame photometry. The blood serum data obtained with the Electrolyte 2 Analyzer are statistically compared with those obtained by flame photometry.     

High-Performance Liquid Chromatographic Determination of SAZ-VII-23, A Novel Antiarrhythmic Agent,in Dog Plasma and Urine

Abstract

A HPLC method has been developed to determine the concentrations of SAZ-VII-23 (3-benzoyl-7-isopropyl-3,7-diazabicyclo[3.3.1]nonane HClO₄), a novel antiarrhythmic agent, in dog plasma and urine. Plasma treated with acetonitrile and alkalinized urine were extracted with chloroform- propanol (9:1). An aliquot was injected on to HPLC system using a C₆ reversed-phase column and acetonitrile-methanol-37.5 mM phosphate buffer, pH 6.8 (28.5:28.5:43 v/v) containing 4.0 mM triethylamine as mobile phase. Detection wavelength was 255 nm. The linear range were 0.04–8 μg/ml, and the lower limit of quantitation was 0.04 μg/ml in plasma and urine, respectively. The method was applied to determine plasma and urine concentrations and preliminary pharmacokinetic profiles of SAZ-VII-23 in a dog.     

High Performance Liquid Chromatographic Assay for Basic Amine Drugs in Plasma and Urine Using a Silica Gel Column and an Aqueous Mobile Phase. II. Chlorpheniramine

Abstract

A high performance liquid chromatographic [HPLC] method that involves the use of a silica gel column and an aqueous mobile phase for quantitation of chlorpheniramine in plasma and urine is presented. Alkalinized samples are cleaned by extraction with pentane [containing 1% CH₃CN], and the extraction is followed by evaporating the solvent and reconstituting the residue in a small amount of mobile phase. An aliquot of this solution is analyzed by an HPLC system with an Ultrasphere Si Column, an aqueous mobile phase at pH 7 containing 60% CH₃CN and 7.5 mM [NH₄]₂HPO₄, and UV detection at 200 nm. Although the average recovery of extraction is 58% ± SD 10%, the detection limit for the method is 0.7 ng/ml in plasma and 100 ng/ml in urine [s/n = 3] for 0.5 ml samples. The coefficients of variation [CV] on the results of samples run to measure interday and intraday precision and the bias on control samples were all 10% or less. We have used the method in a bioavailability study of a controlled release formulation involving over 1000 samples.     

Determination of Steroids in Human Urine by Micellar Liquid Chromatography

Abstract

A simple and sensitive method for the determination of steroids using micellar liquid chromatography is described. The steroids, including hydroxycorticosterone. corticosterone, northisterone, testosterone, mexdroprogesterone acetate and progesterone, were separated by reversed-phase using a micelles mobile phase following UV detection at 245 nm. The parameters affecting retention of the test solutes such as the concentration of sodium dodecyl sulfate (SDS) and n-butanol-1 in the mobile phase were investigated. It was found that the retention of the solutes was dependent on the composition of mobile phase. The linear calibration plots range from 0.1 to 10 μg ml^?1 in mobile phase containing 5.0 × 10^?2 mol l^?1 SDS/9 % n-butanol-1 at pH 6.0, and the detection limit in order of 0.1 μg ml^?1 was obtained. The proposed method was used for the determination of steroids in urine using direct injection of samples without previous treatment.     

A New Method for the HPLC Analysis of Pt(II) in Urine

Abstract

An analytical method has been developed to measure Pt(II) in urine via derivatization and UV or HPLC analysis. A measured quantity of urine is heated briefly with diethyl ammonium diethyl-dithiocarbamate, and the resulting Pt(Et₂NCS₂)₂ is extracted into a measured volume of chloroform. Concentrations of Pt(II) are determined by UV absorption at 346 nm or by reverse phase HPLC analysis. The detection limit for Pt(II) as its dithiocarbamate is ～ 1 ng by HPLC; the concentration limit for HPLC analysis by direct extraction was ～ 25 ng/ml. Chromatographic response was linearly related to Pt(II) concentration over the range 100-4, 000 ng/ml; dilution of more concentrated samples has extended this range to at least 30, 000 ng/ml. This method has been applied to the analysis of Pt(II) in the urine of patients who have received cis-dichlorodiamniineplatinum(II) (CDDP) chemotherapy.     

Multivariate optimization of the hollow fiber-based liquid phase microextraction of lead in human blood and urine samples using graphite furnace atomic absorption spectrometry

The present study developed a liquid-phase microextraction based on hollow fiber coupled with graphite furnace atomic absorption spectrometry for the effective extraction and quantitation of lead from urine and blood samples. A multivariate design was used for the optimization of the experimental conditions to ensure high extraction efficiency. Six factors (solvent type, chelating agent, time extraction, temperature, donor phase pH, and acceptor phase pH) were obtained by screening eleven factors of the Plackett–Burman design; these were optimized using the central composite design of response surface methodology. The optimum conditions of donor phase pH, acceptor phase pH, temperature, and extraction time were 5, 9.5, 40 °C, and 120 min, respectively. In addition, oleic acid containing dicyclohexyl-18-krone-6 was used for the membrane phase. Under optimal conditions, the enrichment factor, limit of detection, and limit of quantification were obtained in the ranges of 21.3–18.7, 0.001–0.002 ng mL^?1, and 0.008–0.01 ng mL^?1, respectively, in urine and blood samples. The linearity of the calibration curve was established for the concentration of Pb in the range of 1–50 ng mL^?1 (r²?=?0.9983). Finally, the performance of the developed method was evaluated for the determination of lead in urine and blood samples, and satisfactory results were obtained (RSDs <?10% with recovery >?95).     

High throughput screening various abused drugs and metabolites in urine by liquid chromatography-heated electrospray ionization/tandem mass spectrometry

An integrated method of liquid chromatography-heated electrospray ionization/tandem mass spectrometry was evaluated for high throughput screening of various abused drugs in urine. Chromatographic analysis was performed on a C18 reverse phase column using a linear gradient of 10 mM ammonium acetate containing 0.1% formic acid-methanol as mobile phase and the total separation time was 7 min. A simple and rapid sample preparation method used was by passing urine samples through a 0.22 μm PVDF syringe filter. The detection limits of the studied abused drugs in urine were from 0.6 ng mL⁻¹ (ketamine) to 9.0 ng mL⁻¹ (norcodeine). According to the results, the linear range was from 1 to 1200 ng mL⁻¹ with relative standard deviation (R.S.D.s) value below 14.8% (intra-day) and 24.6% (inter-day). The feasibility of applying the proposed method to determine various abused drugs in real samples was examined by analyzing urine samples from drug-abused suspects. The abused drugs including ketamines and amphetamines were detected in suspected urine samples. The results demonstrate the suitability of LC-HESI-MS/MS for high throughput screening of the various abused drugs in urine.     

High Performance Liquid Chromatographic Separation of Estradiol-17 α and -17/β in Biological Fluids; Application to Plasma,Milk and Urine of Cows

Abstract

A rapid HPLC technique was developed to separate estradiol epimers. In order to improve the sensitivity of the detection, a radioitmmunoassay was used.

Estrone, estradiol-17α and estradiol-17β were separated within 20 min using 10 ml of chloroform: acetone (90:10), as the mobile phase. The efficiency of the technique was assessed with ₃ steroids and the assay of collected fractions with antlsera specific to each estrogen. Using a non-specific radioimmunoassay, profiles of endogenous estrogens in different biological fluids (blood plasma, milk, urine) were obtained.

The efficiency of HPLC as a separation method and the high sensitivity of radioimmunoassay as a detector allows us to obtain profiles of estrogens from biological samples where steroid concentration is below lOOpg/ml.     

Optimization and Validation of an HPLC-UV Method for Determination of Tranexamic Acid in a Dosage Form and in Human Urine

A simple and reliable high-performance liquid chromatographic method with UV detection at 245 nm has been developed and validated for determination of tranexamic acid (TA) in a dosage form and in human urine. Before injection samples were derivatized with phenyl isothiocyanate (PITC). The reaction temperature, reaction time, and concentration of PITC used for derivatization were optimized. Chromatographic separation was on a C₁₈ column with a 65:35 (v/v) mixture of 10 mM phosphate buffer, pH 3.6, and acetonitrile as mobile phase. Heptaminol hydrochloride was used as internal standard.     

Quantitation of Creatinine in Urine and Plasma Samples by Reversed Phase HPLC

Abstract

Creatinine determination in urine and plasma affords an index of the renal function. Reversed-phase high pressure liquid chromatography was used for the separation and quantitation of creatinine in normal and arsenic exposed human urine samples. Acetonitrile/water (1:1) was the mobile phase. The method was compared with the Jaffé alkaline picrate reaction. Results show that the HPLC procedure has high reproducibility and samples are stable at the storage conditions. Plasma samples required depro-teinization and extraction with CH₃CN prior to HPLC analysis, while urine samples required only centrifugation.     

Rapid High Performance Liquid Chromatographic Determination of Ampicillin in Human Urine

Abstract

A rapid, sensitive and specific HPLC assay for the determination of ampicillin in human urine is developed.

Ampicillin was directly measured in human urine at 225 nm using a reversed phase column (Synchropack RP-P) and a mobile phase composed of (1:9 methanol-sodium acetate solution, 0.01 M, pH 4). The analysis required no longer than 10 min. Linear correlation between the peak height ratio of ampicillin to cefoxitin sodium (internal standard) and ampicillin concentration in urine over the range 10–100 μg ml^?1 was obtained. The developed method proved to be advantageous as it monitors ampicillin level in urine. Moreover, the urinary excretion of ampicillin in human subjects after an oral administration of 500 mg ampicillin capsules was established using the proposed method.     

Rapid Analysis of 6-Diazo-5-oxo-L-norleucine (DON) in Human Plasma and Urine

Abstract

A paired-ion, reversed phase high pressure liquid chromatography (HPLC) procedure is described for the analysis of DON in human plasma and urine. Plasma proteins are removed by centrifugal membrane filtration, and the filtrate is injected directly onto an octadecylsilane column. The DON is eluted in a mobile phase consisting of 5 mM 1-heptanesulfonic acid, pH 2.4. Eluting material is monitored at 280 nm and 254 nm. The lower limit of sensitivity in plasma is 0.1 μg/ml.     

Determination of paraquat in human blood plasma using reversed-phase ion-pair high-performance liquid chromatography with direct sample injection

This report describes the determination of paraquat (PQ) in human blood plasma samples by a direct-injection reversed-phase ion-pair chromatographic method. Blood plasma filtrate was injected directly into the LiChrospher® RP-18 alkyl-diol silica (ADS) precolumn integrated in a column switching system using a mixture of 3% 2-propanol and 10 mM sodium octane sulfonate (SOS) in a 0.05 M phosphate buffer (pH 2.8). After washing with this phase, the ADS precolumn was back-flushed with the analytical mobile phase consisting of 40% of methanol and 10 mM SOS in a 0.05 M phosphate buffer (pH 2.8) at a flow rate of 1.0 ml min⁻¹, in order to carry the analyte to a conventional reversed-phase analytical column, where the separation of PQ was achieved and finally detected by UV at 258 nm. The recoveries of PQ from human blood plasma samples ranged between 95.0 and 99.5% at nine different concentrations (from 0.05 to 3.00 μg of PQ ml⁻¹) with coefficients of variation <2.5% (n=3). The precision expressed as relative standard deviation was below 3.5% for between-day and below 4.3% for within-day measurements (n=5). The detection limit (signal-to-noise ratio, S/N>3) was 0.005 μg ml⁻¹ with an injection volume of 200 μl. The proposed method is promising for the identification and quantification of PQ at low concentration levels and is suitable for its analysis in human blood plasma samples from intentional or accidental poisonings cases with a sample throughput of 5 samples per hour.     

Ion-Paired Liquid Chromatographic Determination of Phenylglyoxal Bis(Guanylhydrazone) in Serum and Urine

Abstract

Phenylglyoxal bis(guanylhydrazone) (PGBG),shows a strong inhibitory activity of the same order and pattern as Methylglyoxal bis (guanylhydrazone) (MGBG), against Diamine oxidase from the small intestine of the rats and against S-adenosylmethionine decarboxylase (one of the key enzymes of polyamine biosinthesis) from Eimeria stiedai cysts, and from partially purified rabbit liver enzyme. The therapeutic interest of polyamine biosynthesis inhibitors in tumoral, infectious and parasitic processes and the lesser toxicity of PGBG than of MGBG favour the use of this compound as an alternative treatment for this kind of disease.

For this study a paired-ion HPLC method was developed to measure concentrations of PGBG in serum and urine samples. The method involved ultrafiltration of diluted serum and urine through a 30,000-Dalton molecular weight cut-off filter.

Recoveries for PGBG in serum and urine were 97–99%. Ultrafiltered samples were then injected into a C₁₈ column and eluted isocratically with a mobile phase consisting of a mixture of phosphate buffer 0.05 M, pH=3.5, methanol (83:17) and 1.5 mM a simple ultrafiltration sample, Ultrafree-MC, system with a molecular weight cut-off of 30,000 Daltons.

The proposed method is practical quick and accurate and requires small sample volumes to determine PGBG in serum and urine.     

Development and validation of a rapid and efficient method for simultaneous determination of methylxanthines and their metabolites in urine using monolithic HPLC columns

A new rapid, sensitive and validated HPLC method has been developed for the determination of methylxanthines and their metabolites in asthmatic patients. The method was initiated by using spiked urine samples on a silica monolithic column as a novel packing material. The mobile phase consisted of 10 mM potassium dihydrogen phosphate buffer/methanol (87.5:12.5 v/v), at a flow rate 1 mL/min. Detection was set at 274 nm. The LOQ for all the compounds ranged from 14 to 41 ng/mL. Excellent linearity was achieved over the studied range of concentration with correlation coefficients 0.9991–0.9998 (n = 6). The developed method was validated by precision and accuracy with RSD <2.55%. On extraction of the drugs and metabolites from the urine samples high recoveries were achieved ranging from 82.06 to 98.34% w/w on RP18 cartridges and methanol/chloroform (20:80 v/v) as the extraction solvent. This method has advantages over other methods using conventional C18 packings.     

Chiral Determination of Salbutamol, Salmeterol and Atenolol by Two-Dimensional LC–LC: Application to Urine Samples

A heart-cut two-dimensional high-performance liquid chromatography method for enantiomeric determination of salbutamol, salmeterol and atenolol in urine is presented. It involves the use of two separations in a liquid chromatography?Cliquid chromatography achiral?Cchiral coupling. Target compounds were previously separated in a primary column (Kinetex? HILIC, 2.6???m, 150?×?2.1?mm I.D.) with a mixture of MeOH:ACN:ammonium acetate buffer (5?mM, pH 6) 90:5:5 (v/v/v) as mobile phase at a flow rate of 0.40?mL?min^?1. Enantiomeric separation was carried out by transferring peak of each compound through a switching valve to a vancomycin chiral column (Chirobiotic? V, 2.6???m, 150?×?2.1?mm I.D.) using MeOH:ammonium acetate buffer (2?mM, pH 4) 97:3 (v/v) as mobile phase at a flow rate of 0.50?mL?min^?1. Ultraviolet detection was done at 227?nm. The method was applied to determine target analytes in urine samples after enzymatic hydrolysis with ??-glucuronidase from Helix pomatia, followed by a solid-phase extraction procedure using Isolute^? HCX mixed-mode cartridges. Extraction recoveries ranged from 82 to 90?% in urine samples. Detection limits were 0.091?C0.095???g for each enantiomer of atenolol and between 0.058 and 0.076 and 0.18?C0.14???g for enantiomers of salbutamol and salmeterol, respectively (3?mL of urine). Linearity ranges were between 0.5 and 10???g?mL^?1. Intraday and interday reproducibilities of enantiomeric ratio and enantiomeric fraction, expressed as relative standard deviation, were between 1.9 and 9.0?%. The optimized method was successfully applied to the analysis of urine samples obtained from excretion studies in volunteers and in freeze-dried urine samples, containing urinary components with MW?<?10,000 and components with MW?>?10,000, spiked with different amounts of studied drugs.     

Optimization and Validation of an LC Method for the Determination of Cefdinir in Dosage Form and Human Urine

A simple and reliable liquid chromatographic method has been developed and validated for the determination of cefdinir in human urine and capsule samples. A chromatographic separation was achieved on a C₁₈ column using a mobile phase consisting of potassium dihydrogen phosphate (10 mM, pH 4.5)–acetonitrile (90:10, v/v). Quantitation was achieved with UV detection at 285 nm, based on peak area with linear calibration curve at a concentration range of 0.7–39 µg mL^?1. This method was successfully applied for the establishment of an urinary excretion pattern after oral dose.     

Optimization and Validation of an LC Method for the Determination of Cefdinir in Dosage Form and Human Urine

A simple and reliable liquid chromatographic method has been developed and validated for the determination of cefdinir in human urine and capsule samples. A chromatographic separation was achieved on a C₁₈ column using a mobile phase consisting of potassium dihydrogen phosphate (10 mM, pH 4.5)–acetonitrile (90:10, v/v). Quantitation was achieved with UV detection at 285 nm, based on peak area with linear calibration curve at a concentration range of 0.7–39 µg mL⁻¹. This method was successfully applied for the establishment of an urinary excretion pattern after oral dose.

     

Determination of Belotecan in the Plasma,Bile, and Urine of Rats by High-Performance Liquid Chromatography with Fluorescence Detection and Its Application to a Pharmacokinetic Study

Abstract

A simple and reliable high-performance liquid chromatographic (HPLC) method was developed for the determination of belotecan in the plasma, urine, and bile samples of rats. Belotecan was analyzed with HPLC using a C18 column with fluorescence detector. A mixture of acetonitrile–0.1 M potassium phosphate buffer at pH 2.4 (25:75, v/v) and 0.2% trifluoroacetic acid was used as the mobile phase. The lower limits of quantitation (LOQ) were 5 ng mL^?1 for the plasma and 5 µg mL^?1 for the urine and bile samples. The method has been readily applied for the routine pharmacokinetic study of belotecan in small laboratory animals.